7+3 (chemotherapy)
ABVD
AL amyloidosis
ATC code L01
Abemaciclib
Aclarubicin
Acronym
Actinomycin
Acute myelogenous leukemia
Acute myeloid leukemia
Acute promyelocytic leukemia
Adagrasib
Adenosine deaminase inhibitor
Adriamycin
Adverse effect
Aflibercept
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anthracycline
Anthraquinone
Antibiotic
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
BCNU
BEACOPP
B cell
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Bisantrene
Bladder cancer
Bleomycin
Bone cancer
Bortezomib
Brain tumor
Brand name
Breast cancer
Breast cancer chemotherapy
Brexucabtagene autoleucel
Busulfan
CAPOX
CBV (chemotherapy)
CEPP
CHOEP
CHOP-R
CHOP (chemotherapy)
COPP (chemotherapy)
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Cardiovascular disease
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
Chemotherapy
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clarithromycin
Clinical trial
Clofarabine
Cocaine
Colorectal cancer
Combination chemotherapy
Copanlisib
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cyclophosphamide, methotrexate and fluorouracil
Cytarabine
Cytostatic
Cytotoxicity
DAC (chemotherapy)
DAT (chemotherapy)
DA (chemotherapy)
DHAP-R
DHAP (chemotherapy)
DNA polymerase inhibitor
DNA replication
DT-PACE
Dacarbazine
Dactinomycin
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dexamethasone
Dicycloplatin
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
Duvelisib
EPOCH-R
EPOCH (chemotherapy)
ESHAP
ESHAP-R
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epinephrine
Epirubicin
Epothilone
Eribulin
Esophageal Cancer
Esophageal cancer
Esophagogastric junction
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
Ewing's sarcoma
Exatecan
FCM-R
FCM (chemotherapy)
FLAG-IDA
FLAG-Ida
FLAG-MITO
FLAG-Mito
FLAG (chemotherapy)
FLAMSA
FLAMSA-BU
FLAMSA-Bu
FLAMSA-MEL
FLAMSA-Mel
FLOT (chemotherapy)
FM-R
FMC-R
FMC (chemotherapy)
FMR (chemotherapy)
FM (chemotherapy)
FOLFIRI
FOLFIRINOX
FOLFOX
Farnesyltransferase inhibitor
Floxuridine
Fludarabine
Fluorouracil
Folinic acid
Follicular lymphoma
Fotemustine
Fuzuloparib
G-CSF
GEMOX
GEMOX-R
GVD (chemotherapy)
Gastric Cancer
Gastric cancer
GemOx
GemOx-R
Gemcitabine
Generic drug
Germ cell tumor
Gimatecan
Glasdegib
HER2/neu
Halogenation
Hdl (identifier)
High-dose chemotherapy
Histone deacetylase inhibitor
Hodgkin's Lymphoma
Hodgkin's lymphoma
Hodgkin lymphoma
Hydrazine
Hydroxycarbamide
Hydroxydaunorubicin
Hyper-CVAD
Hypomethylating agent
IAC (chemotherapy)
IA (chemotherapy)
ICE-R
ICE (chemotherapy)
ICE chemotherapy regimen
IDA-FLAG
IFL (chemotherapy)
IMP dehydrogenase
Ida-FLAG
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
Larotaxel
Lenalidomide
Leucovorin
Leukemia
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of chemotherapeutic agents
List of withdrawn drugs
Lomustine
Lonidamine
Losoxantrone
Lucanthone
Lung cancer
Lurbinectedin
Lurtotecan
Lymphoblastic lymphoma
Lymphoma
Lymphomas
MALT lymphoma
MINE-R
MINE (chemotherapy)
MITO-FLAG
MOPP (chemotherapy)
MOPP (medicine)
M phase
Maintenance therapy
Mannosulfan
Masoprocol
Mechlorethamine
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Mesna
Mesothelioma
Methotrexate
Methyl aminolevulinate
Methylprednisolone
Microtubule
Mito-FLAG
Mitobronitol
Mitoguazone
Mitomycin
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Multiple myeloma
Myelodysplastic syndrome
Nadofaragene firadenovec
National Cancer Institute
National Comprehensive Cancer Network
Navitoclax
Nedaplatin
Nelarabine
Neuroblastoma
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma
Novantrone
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oncology
Oncovin
Oprozomib
Ortataxel
Osteosarcoma
Ovarian cancer
Oxaliplatin
PARP inhibitor
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Pancreatic cancer
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pertuzumab
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Pomalidomide
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Prednisone
Preventive healthcare
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
Purine analogue
Pyrimidine analogue
R-CHOP
R-DHAP
R-EPOCH
R-ESHAP
R-FCM
R-FM
R-FMC
R-GEMOX
R-GemOx
R-ICE
R-MINE
RFM (chemotherapy)
RICE (chemotherapy)
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Refractory disease
Regimen
Relapse
Retinoid
Retinoid X receptor
Rhabdomyosarcoma
Ribociclib
Ribonucleotide reductase inhibitor
Rituximab
Romidepsin
Rubitecan
Rucaparib
S2CID (identifier)
S phase
Satraplatin
Seliciclib
Selinexor
Semustine
Sequential high-dose chemotherapy
Sex steroid
Siewert classification
Silatecan
Sitimagene ceradenovec
Soft-tissue sarcoma
Sotorasib
Spindle poison
Stanford V
Steroid hormone
Streptomyces
Streptozotocin
Synergy
TCH (chemotherapy)
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testicular cancer
Testolactone
Tetracaine
Thalidomide
Therapy
Thiopurine
Thiotepa
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Trastuzumab
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
Umbralisib
Uramustine
VAMP Regimen
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
Wayback Machine
Wilms' tumor
Zorubicin